Core Insights - The event "Hand in Hand with Hong Kong, Discussing the Future" was successfully held in Hong Kong, organized by Shuangyi Pharmaceutical and RaffAello, focusing on corporate development, industry trends, and investment opportunities [1][3] - Chairman Wang Bo emphasized that 2026 is a critical year for Shuangyi Pharmaceutical's transformation and high-quality development, aiming to leverage Hong Kong's international financial advantages to showcase Guangxi's achievements and promote key products globally [3][5] Company Strategy - Shuangyi Pharmaceutical is committed to implementing a "dual brand" strategy, aiming to establish its flagship product, Shuangyi Qushi Tongluo Capsule, as a global leader while also striving to make its compound cold medicine granules a market champion [5] - The company plans to expand its business both domestically and internationally, focusing on product-centric and market-oriented approaches, with a vision to enhance collaboration with partners for broader development opportunities [5] Industry Reception - Attending fund managers praised Shuangyi Pharmaceutical's dedication to ethnic Zhuang medicine and its commitment to independent innovation, recognizing the company's growth journey as a testament to resilience and potential [5] - The overall atmosphere of the event was positive, with deep exchanges and interactions, reflecting the company's commitment to its corporate spirit of unity, diligence, perseverance, and innovation [6]

Core Viewpoint - The collaboration between Guangxi Shuangyi Pharmaceutical Co., Ltd. and Hubei Jinying Agricultural Development Co., Ltd. aims to enhance the quality and stability of the core raw material, wild chrysanthemum, for Shuangyi's flagship product, Shuangyi Compound Cold Medicine Granules, through standardized planting techniques and a comprehensive supply chain [1][9]. Group 1: Company Collaboration - The visit by Shuangyi's chairman and vice president to Hubei Jinying was focused on exploring the entire supply chain of wild chrysanthemum, including breeding, large-scale cultivation, and processing [1][3]. - Hubei Jinying has established a complete industrial chain for traditional Chinese medicine, with 2,580 acres of medicinal herb cultivation, including 1,030 acres dedicated to wild chrysanthemum [6]. - Shuangyi Pharmaceutical recognizes the advantages of Hubei Jinying's breeding and cultivation techniques, expressing a strong intention to introduce these methods to enhance its own herbal medicine cultivation base [9][11]. Group 2: Product Quality and Market Demand - Wild chrysanthemum is a key ingredient for Shuangyi's products, which include various cold and cough remedies, indicating a significant market demand for this raw material [8]. - The use of Hubei's wild chrysanthemum not only improves the efficacy of Shuangyi's products but also strengthens its competitive edge in the market [9]. - Shuangyi emphasizes its commitment to using authentic medicinal materials, which is crucial for maintaining product quality, especially in light of the recent increase in influenza cases [13]. Group 3: Future Cooperation and Development - The visit established a communication bridge for future collaboration, with both companies aiming to explore new cooperation models that promote resource sharing and complementary advantages [15]. - The partnership is expected to contribute to the high-quality development of the traditional Chinese medicine industry and support rural revitalization efforts [15].

Core Insights - The event "2024-2025 Family Essential Medicines, Nutritional Foods/Supplements, Medical Devices, and Disinfectants Brand Awards" was held in Nanjing, showcasing 130 brands across three categories [1] - The awards highlight the professional segmentation and market trends in the family health sector, with specific categories for essential medicines, nutritional foods/supplements, and medical devices/disinfectants [1] Group 1: Award Details - The awards featured three sub-lists: essential medicines covering 34 subcategories, nutritional foods/supplements including 7 categories, and medical devices/disinfectants with 6 categories [1] - The recognition of "Shuangyi Compound Cold Medicine Granules" as a top brand in the essential medicines category reflects its product quality and market reputation [1] Group 2: Market Context - The timing of the award coincides with the peak flu season, enhancing the significance of the recognition for Shuangyi Compound Cold Medicine Granules [2] - The company emphasizes the importance of health protection during temperature fluctuations, promoting its product as a reliable choice for families [2]